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Abstract
Parkinson’s disease (PD) is a progressive neurological disorder of the central nervous sys-
tem that deteriorates motor functions, while it is also accompanied by a large diversity of
non-motor symptoms such as cognitive impairment and mood changes, hallucinations, and
sleep disturbance. Parkinsonism is evaluated during clinical examinations and appropriate
medical treatments are directed towards alleviating symptoms. Tri-axial accelerometers,
gyroscopes, and magnetometers could be adopted to support clinicians in the decision-
making process by objectively quantifying the patient’s condition. In this context, at-home
data collections aim to capture motor function during daily living and unobstructedly assess
the patients’ status and the disease’s symptoms for prolonged time periods. This review
aims to collate existing literature on PD monitoring using inertial sensors while it focuses on
papers with at least one free-living data capture unsupervised either directly or via video-
tapes. Twenty-four papers were selected at the end of the process: fourteen investigated
gait impairments, eight of which focused on walking, three on turning, two on falls, and one
on physical activity; ten articles on the other hand examined symptoms, including bradykine-
sia, tremor, dyskinesia, and motor state fluctuations in the on/off phenomenon. In summary,
inertial sensors are capable of gathering data over a long period of time and have the poten-
tial to facilitate the monitoring of people with Parkinson’s, providing relevant information
about their motor status. Concerning gait impairments, kinematic parameters (such as dura-
tion of gait cycle, step length, and velocity) were typically used to discern PD from healthy
subjects, whereas for symptoms’ assessment, researchers were capable of achieving accu-
racies of over 90% in a free-living environment. Further investigations should be focused on
the development of ad-hoc hardware and software capable of providing real-time feedback
to clinicians and patients. In addition, features such as the wearability of the system and
user comfort, set-up process, and instructions for use, need to be strongly considered in the
development of wearable sensors for PD monitoring.
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Introduction
Parkinson’s disease (PD) is a chronic neurological disorder of the central nervous system. Its
incidence rises dramatically with age, affecting approximately 6.2 million people worldwide in
2015 [1]. The symptoms of PD are multiple, with the most identifiable being related to motor
degeneration. In general, they appear gradually and become more evident with the worsening
of the disease, varying from person to person. The diagnosis of PD can be challenging, espe-
cially at an early stage, due to the lack of specific tests [2]. The most recognizable symptoms
include tremor, rigidity, bradykinesia, and postural instability [3].
Tremor typically appears at the distal part of the limbs, affecting a single arm or leg; it is
more pronounced in the upper extremities and it progresses bilaterally with the degeneration
of the disease. Rigidity refers to an immoderate, continuous contraction of muscles, and an
increased resistance to joint movements. Bradykinesia, as a general term, can be differentiated
into akinesia, bradykinesia and hypokinesia, indicating absence, slow or decreased bodily
movements, respectively. Akinesia may also include the freezing-of-gait (FoG) phenomenon,
which causes sudden and temporary episodes of inability to move forward despite the inten-
tion to walk. Postural instability is related to loss of balance and the inability to maintain the
upright position, often causing falls or a fear of falling [3].
Despite PD being an irreversible neurodegenerative disorder, medications, such as Levo-
dopa can provide symptomatic relief, particularly in earlier stages [4]. The “on” and “off” phe-
nomenon in Levodopa-treated patients, describes motor fluctuations that occur as the levels of
dopamine in the brain drop, followed by a worsening of the motor function: during the "on"
state the symptoms are well managed, while in the "off" state they deteriorate. In newly diag-
nosed people with Parkinson’s (PwP), the response to a single drug intake may last for several
hours, whereas with the progression of the disease the drug’s effect is shortened (4 hours or
less), and patients need to decrease intervals between doses and/or increase the dosages [5, 6].
Drug-induced dyskinesia (i.e. involuntary abnormal muscle movements [7]) can appear dur-
ing the “on” state in some patients who have been taking Levodopa for a prolonged period of
time.
To ensure the appropriate medical treatment and correct dose of medication for an individ-
ual, PwP are infrequently evaluated with qualitative clinical assessments that are based on the
subjective judgment of specialists, such as the Movement Disorder Society—Unified Parkin-
son’s Disease Rating Scale (MDS-UPDRS), or specifically for dyskinesia, the modified Abnor-
mal Involuntary Movement Scale (m-AIMS) [8, 9]. Yet, due to the heterogeneity and
complexity of PD symptoms, such clinical assessments can be challenging and time consum-
ing. Clinicians with different backgrounds and experiences might also vary in their interpreta-
tions of the MDS-UPDRS and m-AIMS [10]. Equally, a person’s motor state at a clinic
appointment may not be typical of their usual state, enhanced by fatigue, dehydration from
travelling or anxiety [10]. Therefore, a clinical assessment is only a snapshot in time, giving lit-
tle indication of function in a more on or off state. Ultimately, the only way to properly charac-
terize a patient’s motor status is to continuously evaluate their motor function over an
extended period of time.
Due to their small-size, light weight, and low-power, wearable motion sensors have already
demonstrated their clinical relevance in healthcare [11–13] and daily-life monitoring [14, 15].
The most widely used sensors are tri-axial accelerometers, gyroscopes, and magnetometers,
commonly combined in an inertial measurement unit (IMU) that can capture three-dimen-
sional orientation, and linear and angular velocities [16, 17]. Thanks to the development of
miniaturized hardware technologies capable of collecting and storing large amount of raw data
[18], IMUs may offer the opportunity to improve the evaluation of the PD motor symptoms
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by collecting free-living movements for prolonged period of time outside the laboratory envi-
ronment. Former studies, such as the one by Bloem et al. [19], have reported that PwP walk
better when observed rather than when unsupervised in their daily lives. This is a consequence
of the well-known “Hawthorne observation effect” [20]: free-living activities involve a combi-
nation of tasks with varying complexities, challenges and distractions that may reduce atten-
tion. In addition, numerous episodes related with PD are challenging to detect during
laboratory-based observation because of their complexity (i.e. the on/off phenomenon) or rar-
ity (i.e. freezing of gait phenomenon) [21]. As a consequence, a thorough evaluation of a PwP
requires the data to be gathered during long observation windows while patients go ahead
with normal every day activities.
Previous reviews have already investigated monitoring of PD using body-fixed-sensors
[22–28]; yet, to our best knowledge, this is the first systematic review to target solely publica-
tions on continuous monitoring of PwP with at least one data capture at home. We focused on
studies that used only wearable inertial sensor over a long period of time (i.e. from one to four-
teen days) and where the data collection was not supervised (either directly or via videotape)
by clinicians or caregivers.
Methodology
This systematic review was performed according to the guidelines of the PRISMA statement
[29]. The literature search was conducted in April 2020 on the IEEE Xplore, PubMed, Spring-
erLink, ACM Digital Library and Web of Science electronic databases with the following
search string:
(Parkins�) AND (bradykinesia OR tremor OR rigidity OR hypokinesia OR dyskinesia OR
freez� OR akinesia OR fluctuat� OR movement disorder) AND (IMU or inertia� OR accel-
er� OR gyro� OR wearable OR body-worn) AND (free-living OR daily-living OR continu-
ous OR 24-hour OR home OR unsupervised)
Only original, full-text, peer-reviewed, journal or conference articles in English that were
published between January 2010 and April 2020 were included in this review. Case studies,
reviews, books, book chapters, editorials, and letters were excluded. Duplicate findings were
manually identified and removed.
Three reviewers (MS, ST, and CC) independently screened the title, abstract and key words
of the records identified through the database searching. Studies were selected if they moni-
tored or estimated the severity of PD symptoms at home with inertial sensors and their data
collection was not supervised by research staff or video cameras. Studies were excluded if the
main recording devices were not IMUs, or PD was not the prevalent disorder of the sample
population. Subsequently, full text assessment was performed by each reviewer and cases of
conflict were debated among them.
The relevant data was extracted from chosen studies and tabularized under predefined
headings. Authorship, symptoms monitored, activities, devices (type, number, placement) and
data collection (number of assessment days, sample size, use of diaries) were all recorded.
Additionally, the studies’ aims, outcome measures, analyses used and results were
summarized.
To analyze the risk of bias of the reviewed studies, an adapted version of the AXIS appraisal
tool for cross-sectional studies was used, containing thirteen questions that could be answered
with a “yes” or “no” [30] (Table 1). A single reviewer scored each study from zero to 13 against
the appraisal tool by summing all the positive answers. Papers were categorized as having low
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(score equal or higher than 11), medium (score between eight and 10) and high (score equal or
lower than seven) risk of bias.
Results
Studies selection
The electronic database searches identified 446 records (Fig 1). Ninety-eight duplicates were
removed and the remaining 348 articles were screened (229 records excluded). Following full
text assessment (95 records excluded) a total of 24 studies were included in the review [31–54].
Risk of bias assessment
The appraisal tool yielded six studies with medium and 18 with low risk of bias. Authors
reported clear aims and objectives (Q1, 95.8%), study designs (Q2, 95.8%) and selection pro-
cesses (Q4, 83.3%), however, the sample size was inadequate in 37.5% of the cases (Q3). The
outcome variables were appropriate to the aims (Q5, 100%) and measured with the correct
instruments (Q6, 100%), while statistics and general methods were reported adequately (Q7,
87.5%; Q8, 79.1%). Results were presented in depth (Q9, 87.5%) and described in the methods
(Q10, 87.5%). Discussions and conclusions were justified by the results (Q11, 100%) with no
conflicts of interests (Q13, 100%), yet, 37.5% of the authors omitted or did not fully investigate
the study’s limitations (Q12). Detailed scores for each level of bias and each individual study
are presented in S1 and S2 Tables.






Q1 1 Were the aims/objectives of the study clear?
METHODS
Q2 2 Was the study design appropriate for the stated aim(s)?
Q3 3, 4 & 5 Was the sample size justified, clearly defined, and taken from an appropriate
population?
Q4 6 Was the selection process likely to select subjects/participants that were
representative of the target/reference population under investigation?
Q5 8 Were the outcome variables measured appropriate to the aims of the study?
Q6 9 Were the outcome variables measured correctly using instruments/
measurements that had been trialed, piloted or published previously?
Q7 10 Is it clear what was used to determined statistical significance and/or precision
estimates? (e.g. p-values, confidence intervals)
Q8 11 Were the methods (including statistical methods) sufficiently described to
enable them to be repeated?
RESULTS
Q9 12 Were the basic data adequately described?
Q10 16 Were the results presented for all the analyses described and presented in the
methods?
DISCUSSION
Q11 17 Were the authors’ discussions and conclusions justified by the results?
Q12 18 Were the limitations of the study discussed?
OTHER
Q13 19 Were there any funding sources or conflicts of interest that may affect the
authors’ interpretation of the results?
https://doi.org/10.1371/journal.pone.0246528.t001
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Characteristics of included studies
Among the 24 identified papers, 15 included sessions that were recorded both at home and in
the lab during one [33, 35, 38–45, 51], two [31, 32], or three visits [36, 37]; these studies
included an initial calibration/validation in a supervised environment for the development of
ad-hoc algorithms and then subsequent implementation/testing in an unsupervised setting.
Besides the number of testing days and lab sessions, the exact duration of each lab assessment
was not always specified, thus hindering the reproducibility of the protocol. In contrast, nine
articles described data collection that was exclusively undertaken at home [34, 46–50, 52–54]
(Table 2).
Sample sizes ranged from seven [31, 41] to 125 [51] PwP, and from nine [31] to 67 [39] con-
trols in laboratory environments. The same numbers for at-home tests ranged from one [33,
52] to 170 [50] PwP, and from one [33] to 172 [50] controls. In 13 cases, PwP were asked to fill
a diary in order to track activities[31, 36, 37, 53], medication intake [31, 32, 34, 35] and symp-
toms [34, 41, 45–47, 52, 54] (Table 2).
Data were collected by accelerometers alone (in 46.7% of the studies recording in labs and
50% of the studies at-home) [33, 35–37, 41, 44–47, 49–51, 53], in combination with gyroscopes
(lab: 33.3%, home: 33.3%) [31–33, 39, 42, 43, 48, 52] or along with gyroscopes and magnetom-
eters (lab: 20%, home: 16.7%) [34, 38, 40, 51, 54]. Authors used off-the-shelf devices such as
the AX3 (Axivity, York, UK) [44, 45, 50, 51], DynaPort (McRoberts, The Hague, Netherlands)
[33, 39, 42, 43, 48], GT3X (ActiGraph, Pensacola, USA) [53], Mimamori-gait system (Mitsu-
bishi Chemical, Tokyo, Japan) [36, 37], Mobi8 (TMSI International, Oldenzaal, The Nether-
lands) [33], MOX5 (Maastricht Instruments, Maastricht, The Netherlands) [52], Opal
(APDM, Portland, USA) [34, 38, 40, 51, 54] and Parkinson’s Kinetigraph (Global Kinetics
Fig 1. PRISMA flow diagram.
https://doi.org/10.1371/journal.pone.0246528.g001
PLOS ONE Systematic review of Parkinson’s disease home monitoring using inertial sensors
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































PLOS ONE Systematic review of Parkinson’s disease home monitoring using inertial sensors







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































PLOS ONE Systematic review of Parkinson’s disease home monitoring using inertial sensors















































































































































































































































































































































PLOS ONE Systematic review of Parkinson’s disease home monitoring using inertial sensors
PLOS ONE | https://doi.org/10.1371/journal.pone.0246528 February 4, 2021 8 / 22
Corporation, Melbourne, Australia) [35, 36]. In five studies, volunteers wore prototype sensors
[31, 32, 41, 47, 49] (Fig 2). Data collection frequently lasted for a week and ranged from one
[31, 36, 37, 41, 46, 47, 49] to 14 days [52] (Fig 3 and Table 2).
Fourteen works investigated gait impairments, eight of which focused on walking [31, 33,
36, 37, 42–44, 51], three on turning [38, 40, 48], two on falls [39, 50] and one on physical
Fig 2. Device–Number of studies.
https://doi.org/10.1371/journal.pone.0246528.g002
Fig 3. Data collection–Number of days.
https://doi.org/10.1371/journal.pone.0246528.g003
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Table 3. Aim, outcome measures, type of analyses, and results of the studies.
Author Study Aim Outcome measures Analysis Results
Moore et al.
(2011) [31]




Mean stride length error was equal to
0.064 ± 0.013 m for controls and
0.045 ± 0.024 m for PD patients.
Moreover, there were considerable
fluctuations in stride length for
patients with a longer duration of the
disease
2-D Plots (24 h activities)
















Home The accuracy between the
Bradykinesia Score outcome and the
UPDRS (clinicians twice per day) was
equal to 68.3 ± 8.9% with the standard





PD gait analysis Temporal measures: average stride
time (s)





Less consistent walking patterns in
PD patients compared to controls.
Moreover, the frequency amplitude
was smaller in PD patients
(0.67 ± 0.22 psd) than in controls
(0.94 ± 0.16 psd)
Frequency measures: stride time
variability (%), dominant
frequency (Hz), amplitude (psd),
width (Hz), and slope (psd/Hz)
Home Results extended in an unsupervised
environment. In particular, frequency
amplitude above 0.3 psd for only 165
minutes in PD and frequency
amplitude above 0.3 psd for 355
minutes in controls.
Das et al. (2012)
[34]
Detection of tremor and
dyskinesia episodes
Tremor episodes (starting time
and duration) Dyskinesia episodes
(starting time and duration)
Dyskinesia and tremor
estimation: ID-APR,
MI-SVM, kNN, DD, and
EM-DD classifiers
Home ID-APR classifier achieved the best
performances with an accuracy
(outcome vs symptoms diary) over












The Bradykinesia Score outcome
(compared to the Bradykinesia Score
dot test) had a specificity of 88% and a
sensitivity of 95%.
Dyskinesia episodes (starting time
and duration)
Bradykinesia Score [0–80] The Dyskinesia Score outcome had a
highly significant correlation with the
AIMS test (Pearson’s p< 0.0001, R of
0.80).
Dyskinesia Score [0–80]
Home Correlation (p < 0.05) between global
median bradykinesia (from 10 days
recording) and UPDRS.
Correlation (p < 0.0005) between
global median dyskinesia (from 10
days recording) and UPDRS
Author Study Aim Outcome measures Analysis Results
Yoneyama et al.
(2013) (Part 1
and 2) [36, 37]
PD gait analysis Number gait peaks, gait cycle (s)
and average acceleration





The accuracy of the gait peaks
detection between the outcome and
the videotape was over 94%
Home Average gait cycle was larger in PD
(1.16 ± 0.20 s) rather than controls
(1.08 ± 0.19 s). In addition, the
recognition of PD gait from a normal
gait had 100% sensitivity, 94.1%
specificity, and 96.3% accuracy.
(Continued)
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Table 3. (Continued)
Author Study Aim Outcome measures Analysis Results
El-Gohary et al.
(2014) [38]
PD turning analysis Number of bouts/h, duration (s),
step duration (s), active-rate (%),
number of turns, number of turns/
h, duration (s) angle (degrees),
peak velocity (degrees/s), and
number of steps
Turn detection algorithm Controlled
environment
The turn detection algorithm
achieved a sensitivity of 90% and 76%
and a specificity of 75% and 65%
when compared respectively with a
motion analysis system and a
videotape.
Home PD tend to take shorter turns with




PD fall risk and gait
analysis
Total number of activity bouts,
total percent of activity duration
(%), total number of steps for
3-days, median activity bout
duration (s), median number of
steps for bout, cadence (steps/
min), amplitude of dominant
frequency (prs), width of
dominant frequency (Hz), stride






Home The walking quantity is similar
between PD fallers and non-fallers,
while fallers had a higher step to step
variability.
Outcomes measures predicted the
time to first fall (p = 0.0034) in PD
patients who reported no falls in the
year prior to testing.
Mancini et al.
(2015) [40]
PD turning analysis Active rate (%),number of turns,
number of turns/hour, turn angle
(degrees), CV turn angle, turn
duration (s), CV turn duration,
number of steps /turn, CV
number of steps /turn, turn mean
velocity (degrees/s), and CV turn
mean velocity
Turn detection algorithm Controlled
environment
Velocity and turn detection were
similar (outcomes vs observed events)
in healthy and PD subjects (p = 0.34
and p = 0.33)
Home PD patients realized the turning
movement slower than the controls
(turn mean velocity 38 ± 5.7˚/s and
43.3 ± 4.8˚/s, respectively) with a
major number of steps (mean number
of steps 3.2 ± 0.8 and 1.7 ± 1.1,
respectively)
Pérez-López
et al. (2015) [41]
Detection of ON/OFF
state











Home ON/OFF classifier, compared to the
self-recorded motor state, had a
sensitivity of 99.9% and a specificity
of 99.9%
Bradykinesia (starting time and
duration) Dyskinesia (starting
time and duration)







PD gait analysis in
patients suffering of
freezing of gait and not
Total number of activity bouts,
total percent of activity duration
(%), total number of steps for
3-days, median activity bout
duration (s), median number of
steps for bout, and cadence (steps/
min), amplitude of dominant
frequency (prs), width of
dominant frequency (Hz), stride






Home Freezers’ walkers had a higher gait
variability (i.e., the anterior–posterior
power spectral density width;
p = 0.003) and a lower gait
consistency (i.e., the vertical stride
regularity; p = 0.007)
Author Study Aim Outcome measures Analysis Results
(Continued)
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Table 3. (Continued)
Author Study Aim Outcome measures Analysis Results
Bernad-Elazari
et al. (2016) [43]
Assessment of PD
conditions
Classification PD vs Healthy, PD







PD vs Healthy: accuracy = 74.6%




PD mild vs Healthy: accuracy = 52.7
Home PD vs Healthy: accuracy = 92.3%
PD mild vs PD severe:
accuracy = 89.8%
PD mild vs Healthy: accuracy = 85.9%Leave-one-out approach
Del Din et al.
(2016) [44]
PD gait analysis Step velocity (m/s), step length
(m), swing time var (s), step
velocity var (m/s), step length var
(m), step time var (s), stance time
var (s), step time (s), swing time
(s), stance time (s), step time asy
(s), swing time asy (s), stance time





2 out of 14 outcomes were
significantly different in PD and
controls.
PD patients walked with slower and
shorter steps (i.e., step velocity
1.254 ± 0.211 m/s and 1.393 ± 0.207
m/s for PD and controls, respectively)
Home 4 out of 14 outcomes were
significantly different in PD and
controls.
PD patients walked with slower and
shorter steps (i.e., step velocity
1.038 ± 0.422 m/s and 1.103 ± 0.411














Classification algorithm vs diary:
ON: sensitivity = 69%,
specificity = 82%
OFF: sensitivity = 60%,
specificity = 83%
Dyskinesia: sensitivity = 49%,
specificity = 99%
Dyskinesia episodes (starting time
and duration)
Home Diary vs ANN
ON: sensitivity = 52%,
specificity = 91%
OFF: sensitivity = 50%,
specificity = 83%













Home The classifier ON/OFF and
Dyskinesia, compared to the diary,
had a moderate-to-strong correlation
(p from 0.404 to 0.658)
Bradykinesia episodes (starting
time and duration)




et al. (2018) [47]
Detection of tremor
episodes





Home Tremor outcome, compared to the
diary, had a sensitivity of 99.3%, a




PD turning analysis in
patients suffering of
freezing of gait and not
Number of turns/30 min, turn
angle (degrees), CV turn angle,
turn duration (s), CV turn
duration, mean velocity (degrees/
s), CV mean velocity, peak
velocity (degrees/s), CV peak
velocity, 2D jerk (m2/s5), CV 2D
jerk, ML jerk (m2/s5), CV ML jerk,
ML range (m2/s), and CV ML
range
Turn detection algorithm Home Similar number of turns in PD
freezers and non-freezers: 19.3 ± 9.2
/30 min and 22.4 ± 12.9 /30 min
respectively (p = 0.194)).
Furthermore, mean jerkiness, mean
and variability of medio-lateral
jerkiness were higher in freezers
(p < 0.05).
Author Study Aim Outcome measures Analysis Results
(Continued)
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activity [53]. Ten articles examined symptoms, side-effects of treatments, and their fluctua-
tions, including two on bradykinesia [32, 35], four on tremor [34, 47, 52, 54], four on dyskine-
sia [34, 35, 45, 46] and four on the on/off state [41, 45, 46, 49] (Table 2). During gait
impairment monitoring, sensors were typically placed at the lower back, in 63.6% and 57.1%
of the works taking place in the lab or at-home, respectively [33, 38, 39, 42–44, 48, 50, 51].
Table 3. (Continued)
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Walk detection
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Home In the control cohort, the algorithm
detected tremor incorrectly 1.1% of
the time or less. Moreover, there was
a good correspondence between
constancy of rest tremor as measured
and UPDRS (ρ = 0:54).
Abbreviations: AIM = abnormal involuntary movements, ANOVA = Analysis of variance, ANN = Artificial Neural Network, asy = asymmetry, CV = Coefficient of
Variation, DD = Diverse Density, EM-DD = Expectation Maximization version of Diverse Density, ICC = Intra Class Correlation, ID-APR = discriminative variant of
the axis-parallel hyper-rectangle, kNN = k-Nearest Neighbor, MI-SVM = Multiple Instance Support Vector Machine, ML = medio-lateral PD = Parkinson’s Disease,
SVM = Support Vector Machine, UPDRS = Unified Parkinson’s Disease Rating Scale, var = variability.
https://doi.org/10.1371/journal.pone.0246528.t003
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Lower back sensors were also combined with IMUs at the top of each foot (lab: 9.1%, home:
14.3%) [38, 40], waist (lab: 18.2%, home: 21.4%) [36, 37, 53], and left shank (lab: 9.1%, home:
7.1%) [31]. To monitor symptoms and their fluctuations, typical sensor positions included the
waist (lab: 25%, home: 20%) [41, 49], wrist (lab: 25%, home: 20%) [35, 46, 47], both wrists (lab:
25%, home: 30%) [45, 52, 54] or in a combination of both ankles and the waist (lab: 25%,
home: 20%) [32, 34] (Table 2).
Aims, outcome measures, and types of analysis
Fourteen articles investigated gait impairments with the aim of assessing different mobility
tendencies and habits in daily life (Tables 2 and 3). Kinematics [31, 33, 36–38, 40, 43, 44], also
in combination with frequency measures [33, 39, 42, 51] were computed to study PD and
healthy subjects [31, 33, 36–38, 40, 43, 44, 53], or different PD populations such as recently
and previously diagnosed patients [31], fallers and non-fallers [39, 50], and subjects with or
without freezing-of-gait [42, 48, 50]. In order to extract kinematic and frequency parameters,
walk detection algorithms were implemented in seven cases [31, 36, 37, 39, 42, 44, 50, 51],
while turning algorithms in three [38, 40, 48].
Ten articles studied symptoms and their fluctuations with the intention of detecting brady-
kinesia [32, 35, 41, 49], tremor [34, 47, 52, 54], dyskinesia [34, 35, 41, 45, 46, 49], and on/off
state episodes [41, 45, 46, 49]. Supervised machine learning approaches, such as Artificial Neu-
ral Networks (ANN) [45], Fuzzy logic algorithms [35], linear regression [52] and Support Vec-
tor Machine (SVM) [32] models were used in this context. One publication used multiple
instance learning algorithms [34], namely, the Diverse Density (DD), Expectation Maximiza-
tion version of Diverse Density (EM-DD), Discriminative variant of the axis-parallel hyper-
rectangle (ID-APR), Multiple instance learning k-Nearest Neighbor (MIL-kNN) and Multiple
Instance Support Vector Machine (MI-SVM). Finally, four studies used thresholds and analy-
ses of frequency patterns [41, 47, 49, 54]. Walk [41, 49, 54] and activity recognition [32] algo-
rithms were also employed in order to assess symptoms during specific patients’ actions
(Tables 2 and 3).
Results of the included studies
Yoneyama et al. (2013/2014) [36, 37] found that the average duration of the gait cycle was lon-
ger in PwP (1.16 ± 0.20 s) compared to controls (1.08 ± 0.19 s; p< 0.001). Similarly, Del Din
et al. (2016) [44] reported that Parkinsonians walked with slower and shorter steps (step veloc-
ity:1.038 ± 0.422 m/s and 1.103 ± 0.411 m/s for PD and controls, respectively; p< 0.001).
Moreover, PwP presented less consistent (e.g. step time variability: 0.175 ± 0.156 s for control
and 0.181 ± 0.179 for PD; p = 0.07) and asymmetric (e.g. step time asymmetry: 0.093 ± 0.086
for control and 0.098 ± 0.142 for PD; p = 0.116) walking patterns [44], with fluctuations in
kinematics and frequency measures compared to healthy subjects [31, 33, 44].
Three studies also investigated turning [38, 40, 48] and confirmed that PwP take shorter
turns (2.0 s and 2.2 s for PD and control, respectively; p = 0.001) with smaller angles (92.0˚
and 95.2˚ for PD and control, respectively; p = 0.001) [38]. In addition, PwP completed the
turning movement at a slower pace than controls (turn mean velocity: 38 ± 5.7˚/s and
43.3 ± 4.8˚/s, respectively; p = 0.04) and with a greater number of steps (mean number of
steps: 3.2 ± 0.8 and 1.7 ± 1.1, respectively; p = 0.04) [40].
One publication investigated the correlation of the monitored overall steps taken (3615/
day) and time spent in moderate-to-vigorous-physical-activities (MVPA, 8.1 min/day) with
the self-reported activity using the Physical Activity Scale in the Elderly–PASE; there was a
moderate correlation for steps (r = 0.56, p = 0.003), but practically no correlation for MVPA (r
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= -0.003, p = 0.98) [53]. Finally, two works estimated that falls occurred most frequently in
PwP with a more variable, less consistent walking pattern [39, 50]; furthermore frequency sen-
sor-derived measures were successfully able to predict future falls even in patients with no pre-
vious fall history [39].
When assessing symptoms at-home, Pastorino et al. [32] classified bradykinesia with respect
to the UPDRS outcome as measured by clinicians twice per day and achieved an accuracy of
68.3 ± 8.9% with the standard SVM and 74.4 ± 14.9% with a meta-analysis algorithm. Das et al.
[34] obtained an accuracy versus symptom diaries of over 90% for both dyskinesia and tremor
detection with a multiple instance learning ID-APR classifier. During a recording of ten days, a
significant correlation (p< 0.0005) with an r = 0.64 between global median bradykinesia and
UPDRS, and a correlation (p< 0.05) with a margin of error of 3.9 (over a range 0–8) between
global median dyskinesia and UPDRS was found by Griffiths et al. [35]. Pérez-López et al. [41]
developed an algorithm for the on/off state events recognition based on threshold detection and
analysis of frequency patterns with a sensitivity of 99.9% and a specificity of 99.9% (compared
to the symptom diary). Rodriguez-Molinero et al. [49] has built upon the previous study,
increasing the sample size to 23 PwP and achieving an accuracy of 92.20%. Fisher et al. [45]
built an ANN classifier that was validated from symptom diaries with a sensitivity ranging from
38% to 52% and specificity from 83% to 93% for the on/off states and for dyskinesia. The
method implemented by Ossig et al. [46] had a moderate-to-strong correlation with subject dia-
ries for on/off states and dyskinesia (p-values ranging from 0.404 to 0.658). For the tremor
assessment, Battista and Romaniello et al. [47] accomplished a sensitivity of 99.3%, a specificity
of 99.6%, and an accuracy of 98.9% as against the tremor diaries; Heijmans et al. [52] reported
correlations of up to r = 0.43, when compared to diaries, while McNames et al. [54] detected
tremor presence (incorrectly) just 1.1% of the time or less in healthy volunteers.
Discussion
The main aim of the present work is to review and compare previous studies on the monitor-
ing of PwP using only wearable inertial sensors and with at least one data capture carried out
during unsupervised home activities. The intent was to inform future works in which the
authors aim to use body-fixed-sensors for extended periods of time in scenarios where data
captures are not monitored either directly or via a videotape.
As a matter of fact, the evaluation of PD requires extensive judgement from highly-trained
professionals, yet clinical assessments in a clinical setting provide only a partial overview of the
disease’s pathological progression [55]. In addition, numerous episodes related with PD are
challenging to detect during laboratory-based short-term observations. To consistently analyse
motor symptoms, fluctuations and gait impairments, long observation windows are required
due to the complexity and sporadicity of such events [21].
Wearable motion sensors are able to monitor PwP outside of standard clinical environ-
ments (for example, in private homes or community dwellings), and provide technically and
clinically relevant information for clinicians and patients; therefore, a continuous assessment
of the pathology may improve the quality of life of PwP, allowing them to preserve their inde-
pendence and avoid additional disease complications. [12, 56, 57].
Characteristics of the studies
For the purpose of gathering large datasets from IMUs recordings lasting from one to 14 days,
the most frequently used off-the-shelf devices were the DynaPort, Opal and AX3 (Fig 2), while
five works used inertial non-commercial prototypes. The majority of the studies adopted off-
the-shelf devices and off-line algorithm solutions. However, a potential implementation of ad-
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hoc hardware and on-board algorithms could enhance real-time feedbacks and ultimately
have a meaningful impact in the life of patients living, for instance, in rural communities and
remote areas [35, 46]. In both cases, the direct manipulation of raw data, gathered during the
free-living acquisitions, avoids the use of aggregated data (i.e. step, distance) generated by
“black box” software of commercial devices.
In the reviewed articles, diaries were completed by PwP or caregivers in order to track daily
activities, medication intake, and symptom occurrences. However, the use of self-report for a
complex task, such as the self-detection and recording of motor status over a prolonged period,
may lead to misinterpretations and errors, particularly in PwP who have impaired cognition
[58]. Patients may not always be able to correctly identify their own motor fluctuations and
symptoms or they may log motor symptoms in incorrect time slots, or forget to update the rec-
ords and then complete them many hours later from a recalled general state of function.
Reportedly, diaries are not a reliable means of comparison; for example, Erb et al. [58] found
that 38% of PwP in this study omitted approximately 25% of entries. However, developing dig-
ital versions, with alerts and prompts, may lessen the drawbacks typically associated with tradi-
tional paper-based diaries for PwP [59], while the involvement of caregivers trained in the data
collection could benefit the quality of the reports.
The number of subjects involved in the data collections is another important aspect with an
impact on the results. Sample sizes varied considerably among studies and ranged from one
[33, 52] to 170 PwP, [50] from one [33] to 172 [50] controls, and from 1 [52] to 342 [50] volun-
teers in total (PwP and controls) in unsupervised environments. No pre-study calculation was
reported in any of the papers to justify the sample size chosen. As a consequence, the small
number of volunteers in certain experimental protocols generated less conclusive and decisive
results in terms of statistical power.
Devices’ number and placement were various, depending on the outcomes measured. Con-
cerning impaired locomotion, the center of mass was extensively used in literature to measure
movement performance and level of stability [60–62]. Accordingly, to monitor activities such
as walking and turning, most of the papers agreed to adopt a single sensor worn close to the
waist [36, 37, 53] and lower back [33, 38, 39, 42–44, 48, 50, 51]. Besides, PwP may exhibit
asymmetric walk due to the different level of impairment of the lower limbs, characterized by
a reduction in walking speed, shuffling steps, and limited foot lifting [3]. Consequently, a sen-
sor attached on the single limb would capture recordings with large variations in gait patterns
and it would give just a partial overview of the patient’s status.
Sensor positioning and number is also crucial for the assessment of multiple symptoms on
different subjects. In fact, tremor, dyskinesia, bradykinesia, and other PD related motor fluctu-
ations affect upper and lower limbs differently depending on the manifestation and stage of
the disease [3]. Thus, a combination of several devices might be more suitable for multiple and
concurrent evaluations, however this would compromise the comfort of the system. Yet, given
that fewer wearable devices enhance the acceptability, wearability and usability of the system, a
sensor on the wrist may offer a good trade-off between applicability and end-user
convenience.
Finally, given the potential continuous long-term adoption of wearable systems by PwP,
aspects which were neglected in the identified papers, such as a system’s comfort of use, set-up
process, instructions for use, support, aesthetics and display, should always be considered to
guarantee long-term acceptability and efficacy of the system. For instance, the FDA-approved
Parkinson’s Kinetigraph system (PKG), which provides continuous, objective, ambulatory
assessments of PD symptoms, has been proved to show high patient acceptability, with 81% of
the users reporting satisfactory outcomes [63]. These considerations are crucial if the final pur-
pose is to gather large datasets and if PwP have to interact on a daily basis with the system.
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Aim, outcome measures, type of analyses, and results
Kinematic parameters, such as duration of gait cycle, step length, and velocity, were clearly dif-
ferentiated between the PD and healthy populations. In fact, PwP walked slower and with
shorter steps [36, 37, 44]. Less consistent gait patterns with major fluctuations in kinematics
and frequency measures were also observed [31, 33, 44]. Findings also underlined differences
in turning [38, 40, 48], showing patients taking shorter turns with smaller angles and complet-
ing the turning movement slower and with a greater number of steps. Concerning the risk of
falling, the relationship between the level of activity and impairments is still a matter of debate
among the scientific community. On one side, more active patients could be more susceptible
to falls since they are exposed to more unsafe situations, but on the other hand they could be at
a lower risk of falling due to a better general health condition. Two reviewed articles estimated
that falls occurred significantly more frequently in PwP with a less consistent walking pattern
[39, 50], while fallers seemed to have a reduced capability to regulate gait due to a partial loss
of postural stability [64]. Inertial wearable device can detect such impaired walking patterns
and predict future falls even in patients with no previous fall history [39].
To evaluate tremor at-home, two papers reported an accuracy against the symptom diary
higher than the 90% [34, 47]. In particular, Battista and Romaniello et al. [47] presented a
promising method based on the spectral analysis of inertial data from a single wrist worn
sensor, in conjunction with the detection of specific movement patterns generally related
with Parkinsonism. To assess bradykinesia and dyskinesia, Griffiths et al. [35] implemented
a fuzzy logic approach using data collected from an accelerometer on the most affected
wrist; these algorithms are the core of the PKG, the first FDA-approved device for the con-
tinuous assessment of PD symptoms. In addition, regarding dyskinesia, Fisher et al. [45]
developed an ANN classifier that was validated from symptom diaries obtaining a promis-
ing level of specificity (93%) but still with a low sensitivity level (38%). Finally, to detect on/
off episodes, Pérez-López et al. [41] and Rodriguez-Molinero et al. [49] developed an algo-
rithm based on the extraction of gait features from an accelerometer on the waist. The algo-
rithm showed an accuracy of 92.2% when compared to the results of the diaries, however
this approach relied upon gait parameters and required patient’s movement; therefore, it
might not be suitable for the recognition during the advanced stage of the disease when
PwP are mostly inactive.
Conclusion
The systematic review included 24 studies on the monitoring of PD using inertial sensors dur-
ing unsupervised home activities. Previous articles already underlined how the well-know
“Hawthorne observation effect” [20] could influence the reliability of data gathered in a labora-
tory setting since participants perform better when completing scripted tasks and while
observed by a clinician. Furthermore, episodes associated with PD usually require long periods
of observation because of their complexity (i.e. the on/off phenomenon) or rarity (i.e. freezing
of gait phenomenon). As a consequence, home based data captures could generate more com-
plete and exhaustive results in the analysis of the Parkinson’s disease.
Fourteen articles focused on postural and gait disturbances [31, 33, 36–40, 42–44, 48, 50,
51, 53] with the intention of evaluating mobility in daily life. The majority of the studies agreed
that a position close to the center of mass (waist or lower back) was ideal for impaired gait
analysis. Kinematic parameters, such as duration of gait cycle, step length, and velocity, were
shown to be capable of discriminating PD and healthy subjects. Furthermore, researchers
reported less consistent gait patterns in patients that may be used to predict falls in the Parkin-
sonian population [39].
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Ten articles investigated symptoms and their fluctuations aiming to detect bradykinesia,
tremor, dyskinesia, and on/off state episodes [32, 34, 35, 41, 45–47, 49, 52, 54]. Even if
researchers were able to achieve accuracies over 90% in a free-living environment [34, 41, 47,
49], the assessment of multiple symptoms on different subjects necessitated the employment
of a high number of wearable devices, compromising the user-friendliness of the system and
patients’ comfort. The wrist position may offer the best compromise between performance,
applicability, and end-user convenience.
In conclusion, future studies commencing an assessment of PwP for prolonged time peri-
ods may look into the a) development and testing of dedicated hardware and software for real-
time feedback that would also permit the interaction between clinicians and patients, and b)
the incorporation of digital versions of diaries with alerts and prompts in the study’s design
that would allow the correlation between quantitative measurements and self-reported out-
comes. Additionally, characteristics which were ignored by researchers, such as the system’s
comfort of use, set-up process, instructions for use, support, aesthetics and display, need to be
strongly considered. These reflections are fundamental for the efficacy of a health care system
that will be used mostly by older people in a social environment and it should not affect
patients physically or psychologically [12, 56, 57, 65–70].
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49. Rodrı́guez-Molinero A, Pérez-López C, Samá A, De Mingo E, Rodrı́guez-Martı́n D, Hernández-Vara J,
et al. A kinematic sensor and algorithm to detect motor fluctuations in Parkinson disease: Validation
study under real conditions of use. J Med Internet Res. 2018. https://doi.org/10.2196/rehab.8335 PMID:
29695377
50. Del Din S, Galna B, Godfrey A, Bekkers EMJ, Pelosin E, Nieuwhof F, et al. Analysis of Free-Living Gait
in Older Adults with and Without Parkinson’s Disease and with and Without a History of Falls: Identifying
Generic and Disease-Specific Characteristics. Journals Gerontol—Ser A Biol Sci Med Sci. 2019.
https://doi.org/10.1093/gerona/glx254 PMID: 29300849
51. Galperin I, Hillel I, Del Din S, Bekkers EMJ, Nieuwboer A, Abbruzzese G, et al. Associations between
daily-living physical activity and laboratory-based assessments of motor severity in patients with falls
and Parkinson’s disease. Park Relat Disord. 2019. https://doi.org/10.1016/j.parkreldis.2019.01.022
PMID: 30718220
52. Heijmans M, Habets J, Kuijf M, Kubben P, Herff C. Evaluation of Parkinson’s Disease at Home: Predict-
ing Tremor from Wearable Sensors. Proceedings of the Annual International Conference of the IEEE
Engineering in Medicine and Biology Society, EMBS. 2019. https://doi.org/10.1109/EMBC.2019.
8857717
53. Mantri S, Wood S, Duda JE, Morley JF. Comparing self-reported and objective monitoring of physical
activity in Parkinson disease. Park Relat Disord. 2019. https://doi.org/10.1016/j.parkreldis.2019.09.004
PMID: 31621608
54. McNames J, Shah V V., Mancini M, Curtze C, El-Gohary M, Aboy M, et al. A Two-Stage Tremor Detec-
tion Algorithm for Wearable Inertial Sensors during Normal Daily Activities. Proceedings of the Annual
International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS. 2019.
https://doi.org/10.1109/EMBC.2019.8857133
55. Jankovic J. Motor fluctuations and dyskinesias in Parkinson’s disease: Clinical manifestations. Mov Dis-
ord. 2005. https://doi.org/10.1002/mds.20458 PMID: 15822109
56. Tedesco S, Sica M, Ancillao A, Timmons S, Barton J, O’Flynn B. Validity evaluation of the fitbit charge2
and the garmin vivosmart HR+ in free-living environments in an older adult cohort. J Med Internet Res.
2019. https://doi.org/10.2196/13084 PMID: 31219048
57. Tedesco S, Sica M, Ancillao A, Timmons S, Barton J, O’Flynn B. Accuracy of consumer-level and
research-grade activity trackers in ambulatory settings in older adults. PLoS One. 2019. https://doi.org/
10.1371/journal.pone.0216891 PMID: 31112585
58. Erb MK, Karlin DR, Ho BK, Thomas KC, Parisi F, Vergara-Diaz GP, et al. mHealth and wearable tech-
nology should replace motor diaries to track motor fluctuations in Parkinson’s disease. npj Digit Med.
2020. https://doi.org/10.1038/s41746-019-0214-x PMID: 31970291
59. Heijmans M, Habets JG V., Herff C, Aarts J, Stevens A, Kuijf ML, et al. Monitoring Parkinson’s disease
symptoms during daily life: a feasibility study. npj Park Dis. 2019. https://doi.org/10.1038/s41531-019-
0093-5 PMID: 31583270
PLOS ONE Systematic review of Parkinson’s disease home monitoring using inertial sensors
PLOS ONE | https://doi.org/10.1371/journal.pone.0246528 February 4, 2021 21 / 22
60. Fazio P, Granieri G, Casetta I, Cesnik E, Mazzacane S, Caliandro P, et al. Gait measures with a triaxial
accelerometer among patients with neurological impairment. Neurol Sci. 2013. https://doi.org/10.1007/
s10072-012-1017-x PMID: 22447360
61. Howell D, Osternig L, Chou LS. Monitoring recovery of gait balance control following concussion using
an accelerometer. J Biomech. 2015. https://doi.org/10.1016/j.jbiomech.2015.06.014 PMID: 26152463
62. Betker AL, Szturm T, Moussavi Z. Center of mass approximation during walking as a function of trunk
and swing leg acceleration. Annual International Conference of the IEEE Engineering in Medicine and
Biology—Proceedings. 2006. https://doi.org/10.1109/IEMBS.2006.259881
63. Dominey T, Hutchinson L, Pearson E, Murphy F, Bell L, Carroll C. Evaluating the clinical utility of the
Parkinson’s KinetiGraph (PKGTM) in the remote management of Parkinson’s disease. Mov Disord.
2018.
64. Schaafsma JD, Giladi N, Balash Y, Bartels AL, Gurevich T, Hausdorff JM. Gait dynamics in Parkinson’s
disease: Relationship to Parkinsonian features, falls and response to levodopa. J Neurol Sci. 2003.
https://doi.org/10.1016/S0022-510X(03)00104-7
65. Giansanti D, Maccioni G, Morelli S. An experience of health technology assessment in new models of
care for subjects with Parkinson’s disease by means of a new wearable device. Telemed e-Health.
2008. https://doi.org/10.1089/tmj.2007.0078 PMID: 18578682
66. Cancela J, Pastorino M, Arredondo MT, Nikita KS, Villagra F, Pastor MA. Feasibility study of a wearable
system based on a wireless body area network for gait assessment in Parkinson’s disease patients.
Sensors (Switzerland). 2014. https://doi.org/10.3390/s140304618 PMID: 24608005
67. Cancela J, Pastorino M, Tzallas AT, Tsipouras MG, Rigas G, Arredondo MT, et al. Wearability assess-
ment of a wearable system for Parkinson’s disease remote monitoring based on a body area network of
sensors. Sensors (Switzerland). 2014. https://doi.org/10.3390/s140917235 PMID: 25230307
68. Piro NE, Baumann L, Tengler M, Piro L, Blechschmidt-Trapp R. Telemonitoring of patients with Parkin-
son’s disease using inertia sensors. Appl Clin Inform. 2014. https://doi.org/10.4338/ACI-2014-04-RA-
0046 PMID: 25024764
69. Ferrari A, Ginis P, Nieuwboe A, Greenlaw R, Muddiman A, Chiari L. Handling gait impairments of per-
sons with Parkinson’s disease by means of real-time biofeedback in a daily life environment. Lecture
Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture
Notes in Bioinformatics). 2016. https://doi.org/10.1007/978-3-319-39601-9_22
70. Fisher JM, Hammerla NY, Rochester L, Andras P, Walker RW. Body-Worn Sensors in Parkinson’s Dis-
ease: Evaluating Their Acceptability to Patients. Telemed e-Health. 2016. https://doi.org/10.1089/tmj.
2015.0026 PMID: 26186307
PLOS ONE Systematic review of Parkinson’s disease home monitoring using inertial sensors
PLOS ONE | https://doi.org/10.1371/journal.pone.0246528 February 4, 2021 22 / 22
